SurvivorNet Connect Presents:
Key Developments in Ovarian Cancer in The Age of COVID-19 and Beyond
Thousands of physicians are struggling with new treatment protocols in the age Covid-19. On May 15th SurvivorNet held a collaborative conversation where opinion leaders addressed key topics. Please enjoy the recap of our discussion below.
Discussion Highlights
-
There only one thing that can go here people, a header.
-
There only one thing that can go here people, a header.
-
There only one thing that can go here people, a header.
-
There only one thing that can go here people, a header.
Please join us for this important meeting as key opinion leaders
address crucial topics and answer questions from colleagues. Our
goal is to support you with excellent information and a review
of the evolving data around treatment protocols & COVID-19. We
will also cover the latest approvals and clinical developments
shaping our field.
We'd like to support you during this challenging time, and this
meeting is intended for healthcare providers only. It is
produced by SurvivorNet's award-winning editorial team. The
content is 100% editorially independent.
Thousands of physicians are struggling with new treatment protocols in the age Covid-19. Our discussion engages leading voices on the latest insights for treating ovarian cancer patients in the age of coronavirus, diving into the important data and approvals which are so rapidly evolving in our field.
Join us online
Friday May 15th
4:00 (EST)